GETTING MY AX-15836 TO WORK

Procedure with SR18662 drastically minimizes development and proliferation of CRC cells. SR18662 reveals improved efficacy in cutting down viability of several CRC cell traces. Flow cytometry Investigation following SR18662 therapy exhibits a rise in cells captured in either S or G2/M phases with the cell cycle and an important increase in the volu